BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30243796)

  • 1. Spinal cord astrocytomas: progresses in experimental and clinical investigations for developing recovery neurobiology-based novel therapies.
    Teng YD; Abd-El-Barr M; Wang L; Hajiali H; Wu L; Zafonte RD
    Exp Neurol; 2019 Jan; 311():135-147. PubMed ID: 30243796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy: A Potential Approach for High-Grade Spinal Cord Astrocytomas.
    Hu J; Liu T; Han B; Tan S; Guo H; Xin Y
    Front Immunol; 2020; 11():582828. PubMed ID: 33679686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
    Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
    World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database.
    Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Jallo GI
    J Neurosurg Pediatr; 2017 Jun; 19(6):711-719. PubMed ID: 28362182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
    Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
    Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.
    McGirt MJ; Goldstein IM; Chaichana KL; Tobias ME; Kothbauer KF; Jallo GI
    Neurosurgery; 2008 Jul; 63(1):55-60; discussion 60-1. PubMed ID: 18728568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in intramedullary astrocytomas: a literature review.
    Benes V; Barsa P; Benes V; Suchomel P
    Eur Spine J; 2009 Oct; 18(10):1397-422. PubMed ID: 19562388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
    Maria BL; Gupta N; Gilg AG; Abdel-Wahab M; Leonard AP; Slomiany M; Wheeler WG; Tolliver LB; Babcock MA; Lucas JT; Toole BP
    J Child Neurol; 2008 Oct; 23(10):1214-20. PubMed ID: 18952588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramedullary spinal cord astrocytomas in children.
    Townsend N; Handler M; Fleitz J; Foreman N
    Pediatr Blood Cancer; 2004 Nov; 43(6):629-32. PubMed ID: 15390309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective observational study on the treatment outcomes of 26 patients with spinal cord astrocytoma including two cases of malignant transformation.
    Ryu SJ; Kim JY; Kim KH; Park JY; Kuh SU; Chin DK; Kim KS; Cho YE; Kim SH
    Eur Spine J; 2016 Dec; 25(12):4067-4079. PubMed ID: 26984877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramedullary spinal cord tumors: a review of current and future treatment strategies.
    Tobin MK; Geraghty JR; Engelhard HH; Linninger AA; Mehta AI
    Neurosurg Focus; 2015 Aug; 39(2):E14. PubMed ID: 26235012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD133 as a Putative Prognostic Biomarker to Predict Intracranial Dissemination of Primary Spinal Cord Astrocytoma.
    Inoue T; Endo T; Nakamura T; Shibahara I; Endo H; Tominaga T
    World Neurosurg; 2018 Feb; 110():e715-e726. PubMed ID: 29180077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients.
    Chamoun RB; Alaraj AM; Al Kutoubi AO; Abboud MR; Haddad GF
    Acta Neurochir (Wien); 2006 Feb; 148(2):175-9; discussion 180. PubMed ID: 16374565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric intramedullary spinal cord tumors: a single center experience.
    Kutluk T; Varan A; Kafalı C; Hayran M; Söylemezoğlu F; Zorlu F; Aydın B; Yalçın B; Akyüz C; Büyükpamukçu M
    Eur J Paediatr Neurol; 2015 Jan; 19(1):41-7. PubMed ID: 25457509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic basis of intradural spinal tumors and its impact on clinical treatment.
    Karsy M; Guan J; Sivakumar W; Neil JA; Schmidt MH; Mahan MA
    Neurosurg Focus; 2015 Aug; 39(2):E3. PubMed ID: 26235020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: High-grade intramedullary astrocytomas: what is the best surgical option?
    Fehlings MG; Craciunas SC
    J Neurosurg Spine; 2010 Feb; 12(2):141-2; discussion 142-3. PubMed ID: 20121347
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and clinical prognostic factors for favorable outcome following surgical resection of adult intramedullary spinal cord astrocytomas.
    Xiao R; Abdullah KG; Miller JA; Lubelski D; Steinmetz MP; Shin JH; Krishnaney AA; Mroz TE; Benzel EC
    Clin Neurol Neurosurg; 2016 May; 144():82-7. PubMed ID: 26999530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord astrocytoma: multidisciplinary experience.
    Tovar Martín MI; López Ramírez E; Saura Rojas E; Arregui Castillo G; Zurita Herrera M
    Clin Transl Oncol; 2011 Mar; 13(3):185-8. PubMed ID: 21421463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of intramedullary spinal cord tumors and therapeutic implications.
    Parsa AT; Fiore AJ; McCormick PC; Bruce JN
    J Neurooncol; 2000 May; 47(3):239-51. PubMed ID: 11016741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
    Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
    Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.